ProKidney Corp. beat EPS estimates 33% of the time across 3 reported quarters (1 beats, 2 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.13 | $-0.15 | -15.4% | Miss |
| Q12026 FY2026 | $-0.13 | $-0.14 | -7.7% | Miss |
| Q42025 FY2025 | $-0.16 | $-0.14 | +12.5% | Beat |
Back to PROK overview · PROK holders · PROK KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.